Amputation, Rehabilitation, Prosthetics, and Palliative Limb Care

42.1Definition and presentation

Major amputation and palliative limb care are definitive management endpoints for chronic limb-threatening ischemia (CLTI) and acute limb ischemia, rather than treatment failures outside of vascular care. The condition is managed by identifying whether a revascularization procedure, an amputation, or a palliative limb plan is most likely to produce a healed, useful, and goal-concordant outcome ACC/AHA PAD Guideline (2024) · ESC PAD Guideline (2024) · Global Vascular Guidelines (2019).

Presenting triggers that shift management toward primary amputation or palliation include:

• Unsalvageable limb anatomy or severe uncontrollable foot infection
• Prohibitive physiological and operative risk
• Limited life expectancy
• Poor expected functional benefit from attempted salvage

42.2Epidemiology and risk prediction

Major lower-extremity amputation is a high-risk operation with substantial early mortality and wide incidence variation across health systems Amputation Mortality SR · 2021 · Contemporary LEA Outcomes (2019) · VASCUNET Amputation Report (2018). In the AMPREDICT MoRe registry of 9,221 veterans undergoing incident dysvascular transmetatarsal, transtibial, or transfemoral amputation, 1-year outcomes distributed as 57.7% surviving without re-amputation, 22.9% surviving with re-amputation, 14.3% death without re-amputation, and 5.1% death with re-amputation AMPREDICT More · 2025.

42.3Limb salvage versus amputation versus palliation

The decision between revascularization and amputation balances technical salvage capability against the competing risks of death and major adverse limb events (MALE) BEST-CLI (2022). In BEST-CLI Cohort 1, representing 1,420 patients with an adequate single-segment great saphenous vein, the composite of MALE or death at a median 2.7 years was 42.6% for surgical bypass and 57.4% for endovascular intervention. In BASIL-2, which randomized 345 patients requiring infrapopliteal revascularization, an endovascular-first strategy reduced the composite of major amputation or death compared to bypass-first (adjusted HR 1.35), with mortality at 45% endovascular versus 53% bypass BASIL-2 (2023).

Primary amputation is indicated when revascularization is futile, anatomically unsuitable, physiologically excessive, or contrary to the patient's goals. Secondary amputation follows a limb-salvage attempt that fails to create a healable or useful limb ACC/AHA PAD Guideline (2024) · ESC PAD Guideline (2024) · Global Vascular Guidelines (2019).

These pathways describe the elective weighing in CLTI. An irreversibly ischemic, nonviable limb (Rutherford class IIb/III acute limb ischemia beyond salvage) or life-threatening wet gangrene with sepsis mandates emergency primary amputation for source control, bypassing staged salvage evaluation ACC/AHA PAD Guideline (2024) · ESC PAD Guideline (2024). The stepwise decision sequence in severe limb threat requires a multidisciplinary evaluation:

1. Confirm limb-salvage potential based on arterial anatomy, infection control, and baseline function.
2. Select primary amputation if revascularization is physiologically prohibitive or lacks functional benefit.
3. Proceed to secondary amputation if preceding salvage efforts are exhausted or fail.
4. Transition to palliative limb care if surgery poses unacceptable risk or conflicts with care goals.

42.4Operative level selection and rehabilitation

Amputation level selection balances the reliable healing of a proximal level against the greater functional preservation of a distal level. Healing prediction at a candidate level rests on transcutaneous oxygen pressure, skin perfusion pressure, toe and ankle pressures, and clinical judgment of tissue viability and the soft-tissue envelope; the risk of non-healing and subsequent re-amputation is weighed heavily during surgical planning Global Vascular Guidelines (2019) · VA/DoD Amputation Rehab Guideline (2017) · Danish Re-amputation Cohort (2024). Working cutoffs anchor the level. Transcutaneous oxygen pressure above 40 mmHg at the candidate site predicts reliable healing, values below 20 mmHg strongly predict non-healing, and 20 to 40 mmHg is indeterminate; skin perfusion pressure at or above 30 mmHg and toe pressure at or above 30 mmHg, with ankle pressure above 50 to 70 mmHg, support healing at a more distal level. Through-knee and above-knee amputations represent distinct surgical strategies and functional endpoints, selected based on the probability of healing and the residual-limb requirements for rehabilitation Through-knee vs Above-knee Review (2022).

Rehabilitation planning begins prior to amputation. Preoperative assessment defines prosthetic candidacy, residual-limb needs, functional goals, and the discharge destination VA/DoD Amputation Rehab Guideline (2017). Prosthetic prescription is governed by the Medicare Functional Classification Level (K-level), which sets component eligibility.

42.5Medical therapy and secondary prevention

Best medical therapy continues regardless of the revascularization or amputation decision. Foundational regimens include antithrombotic therapy, lipid lowering, blood-pressure management, glycemic control, and preventive foot care Global Vascular Guidelines (2019).

For patients with symptomatic peripheral artery disease undergoing lower-extremity revascularization, the addition of rivaroxaban 2.5 mg twice daily to aspirin reduces the composite of acute limb ischemia, major amputation for vascular causes, myocardial infarction, ischemic stroke, or cardiovascular death by 15% (HR 0.85), accompanied by an increase in ISTH major bleeding (HR 1.42) VOYAGER PAD · 2020.

42.6Palliative limb care

Palliative limb care is an active management strategy focusing on symptoms, daily burden, and functional trade-offs when revascularization or major amputation will not yield a healed and useful limb CLTI QoL Meta-analysis (2022) · AMPDECIDE (2024). The plan directly targets pain control, tissue loss, and infection risk in alignment with the patient's goals Palliative Limb Care Cohort (2022).

Early palliative consultation prevents restricting symptom-directed care strictly to the final hours of life in frail patients End-Of-Life CLTI · 2024 · CLTI Palliative Consultation (2023). Palliative care remains demonstrably underutilized in advanced CLTI, representing a gap in standardizing non-procedural goals of care Medicare Palliative Underuse (2023).

Postoperative and longitudinal follow-up anticipates specific clinical failure modes. Surveillance targets wound failure, medical decompensation, discharge-plan collapse, re-amputation, contralateral limb threat, and subsequent cardiovascular events, though hard surveillance intervals are determined clinically rather than universally set Danish Re-amputation Cohort (2024) · UK NVR Risk Model (2020).

42.7Areas of controversy

The direct comparison of BEST-CLI and BASIL-2 amputation outcomes is complicated by differing anatomical levels (infrainguinal versus infrapopliteal) and differing primary strategies (surgical-first versus endovascular-first) BASIL-2 (2023) · BEST-CLI (2022). In addition, landmark trials use composite endpoints such as MALE (which includes above-ankle amputation and reintervention) or combined cardiovascular and limb events; because individual components do not carry equal clinical weight, composite hazard ratios cannot be isolated as pure major-amputation predictors VOYAGER PAD · 2020. Finally, registry-derived predictive models evaluating amputation survival and re-amputation, such as AMPREDICT MoRe and UK National Vascular Registry risk tools, are based on specific national or predominantly male cohorts and require broader validation for civilian and female populations AMPREDICT More · 2025 · UK NVR Risk Model (2020).